Your browser doesn't support javascript.
loading
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
Portaccio, Emilio; Betti, Matteo; De Meo, Ermelinda; Addazio, Ilaria; Pastò, Luisa; Razzolini, Lorenzo; Totaro, Rocco; Spitaleri, Daniele; Lugaresi, Alessandra; Cocco, Eleonora; Onofrj, Marco; Di Palma, Franco; Patti, Francesco; Maimone, Davide; Valentino, Paola; Torri Clerici, Valentina; Protti, Alessandra; Ferraro, Diana; Lus, Giacomo; Maniscalco, Giorgia Teresa; Brescia Morra, Vincenzo; Salemi, Giuseppe; Granella, Franco; Pesci, Ilaria; Bergamaschi, Roberto; Aguglia, Umberto; Vianello, Marika; Simone, Marta; Lepore, Vito; Iaffaldano, Pietro; Comi, Giancarlo; Filippi, Massimo; Trojano, Maria; Amato, Maria Pia.
Affiliation
  • Portaccio E; Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy. emilio.portaccio@unifi.it.
  • Betti M; Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
  • De Meo E; Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
  • Addazio I; NMR Research Unit, Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Pastò L; Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
  • Razzolini L; Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
  • Totaro R; Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
  • Spitaleri D; San Salvatore Hospital, L'Aquila, Italy.
  • Lugaresi A; AORN San G. Moscati, Avellino, Italy.
  • Cocco E; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
  • Onofrj M; Dipartimento Di Scienze Biomediche E Neuromotorie, Università Di Bologna, Bologna, Italy.
  • Di Palma F; University of Cagliari, Cagliari, Italy.
  • Patti F; University G. d'Annunzio Di Chieti-Pescara, Chieti, Italy.
  • Maimone D; ASST Lariana Ospedale S. Anna, Como, Italy.
  • Valentino P; University of Catania, Catania, Italy.
  • Torri Clerici V; UOS Sclerosi Multipla, Policlinico G Rodolico-San Marco, University of Catania, Catania, Italy.
  • Protti A; Centro Sclerosi Multipla, Azienda Ospedaliera Cannizzaro, Catania, Italy.
  • Ferraro D; Institute of Neurology, University Magna Graecia, Catanzaro, Italy.
  • Lus G; Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.
  • Maniscalco GT; Niguarda Hospital, Milan, Italy.
  • Brescia Morra V; Department of Neurosciences, Ospedale Civile Di Baggiovara, Azienda Ospedaliero-Universitaria Di Modena, Modena, Italy.
  • Salemi G; University of Campania Luigi Vanvitelli, Naples, Italy.
  • Granella F; A Cardarelli Hospital, Naples, Italy.
  • Pesci I; Federico II University, Naples, Italy.
  • Bergamaschi R; Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, Palermo, Italy.
  • Aguglia U; University of Parma, Parma, Italy.
  • Vianello M; Ospedale VAIO Di Fidenza AUSL PR, Fidenza (PR), Italy.
  • Simone M; IRCCS Fondazione Mondino, Pavia, Italy.
  • Lepore V; Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Iaffaldano P; Ca' Fancello Hospital, AULSS2, Treviso, Italy.
  • Comi G; Pediatric MS Center, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy.
  • Filippi M; Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Trojano M; Department of Translational Biomedicine and Neurosciences, University of Bari Aldo Moro, DiBraiN, Bari, Italy.
  • Amato MP; Casa Di Cura del Policlinico, Vita-Salute San Raffaele University, Milan, Italy.
J Neurol ; 2024 May 28.
Article in En | MEDLINE | ID: mdl-38805052
ABSTRACT

OBJECTIVES:

We investigated the occurrence and relative contribution of relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA) to confirmed disability accrual (CDA) and transition to secondary progression (SP) in relapsing multiple sclerosis (MS).

METHODS:

Relapsing-onset MS patients with follow-up > / = 5 years (16,130) were extracted from the Italian MS Registry. CDA was a 6-month confirmed increase in Expanded Disability Status Scale (EDSS) score. Sustained disability accumulation (SDA) was a CDA with no EDSS improvement in all subsequent visits. Predictors of PIRA and RAW and the association between final EDSS score and type of CDA were assessed using logistic multivariable regression and multivariable ordinal regression models, respectively.

RESULTS:

Over 11.8 ± 5.4 years, 16,731 CDA events occurred in 8998 (55.8%) patients. PIRA (12,175) accounted for 72.3% of CDA. SDA occurred in 8912 (73.2%) PIRA and 2583 (56.7%) RAW (p < 0.001). 4453 (27.6%) patients transitioned to SPMS, 4010 (73.2%) out of 5476 patients with sustained PIRA and 443 (24.8%) out of 1790 patients with non-sustained PIRA. In the multivariable ordinal regression analysis, higher final EDSS score was associated with PIRA (estimated coefficient 0.349, 95% CI 0.120-0.577, p = 0.003).

DISCUSSION:

In this real-world relapsing-onset MS cohort, PIRA was the main driver of disability accumulation and was associated with higher disability in the long term. Sustained PIRA was linked to transition to SP and could represent a more accurate PIRA definition and a criterion to mark the putative onset of the progressive phase.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurol Year: 2024 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurol Year: 2024 Document type: Article Affiliation country: Italy
...